Heart failure drug vericiguat put to the test in small trial
Disease control
Completed
This completed phase 4 trial tested whether vericiguat, a drug already approved for heart failure, can improve blood vessel function, reduce inflammation, and enhance quality of life in 26 people with heart failure with reduced ejection fraction. Participants received either veri…
Phase: PHASE4 • Sponsor: Josef Stehlik • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC